{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-11-16T04:46:35.507901+00:00","published_at":"2026-11-16T04:46:35.507901+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:f5o4ppp5pv3b","event_type":"CEO_ROLE_RECORDED","effective_at":"2026-02-27","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:michael-s-weiss","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:8f59b28ba2b578ae38e7f53bbfcd66fbbf572071fc3160d264cef18277d0df11"],"summary":"Michael S. Weiss executive of TG THERAPEUTICS, INC., effective 2026-02-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:rq591d1xgj7ol","event_type":"CFO_ROLE_RECORDED","effective_at":"2026-02-27","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:sean-a-power","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:e20f83e9c2ff497228a0914a5a20eb8274272517dbf410957b64a005657f77f5"],"summary":"Sean A. Power executive of TG THERAPEUTICS, INC., effective 2026-02-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:d8yavp1uouc5n","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:sagar-lonial","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Sagar Lonial seat on TG THERAPEUTICS, INC., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1iux85t1nq920j","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:committee:tg-therapeutics-inc:compensation-nominating-and-governance-chair","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Compensation; Nominating and Governance · Chair committee of TG THERAPEUTICS, INC., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cz7zxt22vwrr","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:sagar-lonial","alpha:committee:tg-therapeutics-inc:compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Sagar Lonial member of Compensation; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1s3umr0dtxfei","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:daniel-hume","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Daniel Hume seat on TG THERAPEUTICS, INC., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:x005p6194qibq","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:committee:tg-therapeutics-inc:audit-nominating-and-governance","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Audit; Nominating and Governance committee of TG THERAPEUTICS, INC., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wpnplp13tcl7","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:daniel-hume","alpha:committee:tg-therapeutics-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Daniel Hume member of Audit; Nominating and Governance, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ne0a381jwhl7u","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:kenneth-hoberman","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Kenneth Hoberman seat on TG THERAPEUTICS, INC., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yox3ie1a8msw6","event_type":"COMMITTEE_CREATED","effective_at":"2014-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:committee:tg-therapeutics-inc:audit-compensation-chair","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Audit; Compensation · Chair committee of TG THERAPEUTICS, INC., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:40pytiuteq5s","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2014-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:kenneth-hoberman","alpha:committee:tg-therapeutics-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Kenneth Hoberman member of Audit; Compensation · Chair, effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16im7jrxoz8vz","event_type":"DIRECTOR_APPOINTED","effective_at":"2012-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:laurence-n-charney","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Laurence N. Charney seat on TG THERAPEUTICS, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6c0cl9q63yyj","event_type":"DIRECTOR_APPOINTED","effective_at":"2012-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:yann-echelard","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Yann Echelard seat on TG THERAPEUTICS, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jt7pb7ufk4jz","event_type":"COMMITTEE_CREATED","effective_at":"2012-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:committee:tg-therapeutics-inc:audit-chair","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Audit · Chair committee of TG THERAPEUTICS, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1cq8ims1yki770","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2012-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:laurence-n-charney","alpha:committee:tg-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Laurence N. Charney member of Audit · Chair, effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lev0c416zxrya","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2012-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:yann-echelard","alpha:committee:tg-therapeutics-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Yann Echelard member of Audit; Nominating and Governance, effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19fgrq9268s0l","event_type":"DIRECTOR_APPOINTED","effective_at":"2011-01-01","detected_at":"2026-11-16T04:46:35.507901+00:00","subject_ids":["alpha:person:michael-s-weiss","alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a"],"caused_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"summary":"Michael S. Weiss seat on TG THERAPEUTICS, INC., effective 2011-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daniel-hume","object_label":"Daniel Hume","object_source_name_forms":[],"value":"Daniel Hume: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:daniel-hume","name":"Daniel Hume"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kenneth-hoberman","object_label":"Kenneth Hoberman","object_source_name_forms":[],"value":"Kenneth Hoberman: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kenneth-hoberman","name":"Kenneth Hoberman"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:laurence-n-charney","object_label":"Laurence N. Charney","object_source_name_forms":[],"value":"Laurence N. Charney: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:laurence-n-charney","name":"Laurence N. Charney"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-weiss","object_label":"Michael S. Weiss","object_source_name_forms":[],"value":"Michael S. Weiss: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-weiss","name":"Michael S. Weiss"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2011-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2011-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2011-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sagar-lonial","object_label":"Sagar Lonial","object_source_name_forms":[],"value":"Sagar Lonial: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sagar-lonial","name":"Sagar Lonial"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yann-echelard","object_label":"Yann Echelard","object_source_name_forms":[],"value":"Yann Echelard: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yann-echelard","name":"Yann Echelard"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:12","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-s-weiss","object_label":"Michael S. Weiss","object_source_name_forms":[],"value":"Michael S. Weiss: Chairman, Chief Executive Officer and President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-s-weiss","name":"Michael S. Weiss"},"title":"Chairman, Chief Executive Officer and President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-27","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:8f59b28ba2b578ae38e7f53bbfcd66fbbf572071fc3160d264cef18277d0df11","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TGTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/tgtx20251231_10k.htm","source_date":"2026-02-27T00:00:00+00:00","retrieved_at":"2026-05-03T19:25:37.394633+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-27T00:00:00+00:00","effective_from":"2026-02-27","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:13","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sean-a-power","object_label":"Sean A. Power","object_source_name_forms":[],"value":"Sean A. Power: Chief Financial Officer, Treasurer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sean-a-power","name":"Sean A. Power"},"title":"Chief Financial Officer, Treasurer and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-27","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:e20f83e9c2ff497228a0914a5a20eb8274272517dbf410957b64a005657f77f5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TGTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/tgtx20251231_10k.htm","source_date":"2026-02-27T00:00:00+00:00","retrieved_at":"2026-05-03T19:25:37.928829+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-27T00:00:00+00:00","effective_from":"2026-02-27","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:8f59b28ba2b578ae38e7f53bbfcd66fbbf572071fc3160d264cef18277d0df11","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TGTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/tgtx20251231_10k.htm","source_date":"2026-02-27T00:00:00+00:00","retrieved_at":"2026-05-03T19:25:37.394633+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e20f83e9c2ff497228a0914a5a20eb8274272517dbf410957b64a005657f77f5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TGTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/tgtx20251231_10k.htm","source_date":"2026-02-27T00:00:00+00:00","retrieved_at":"2026-05-03T19:25:37.928829+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.829,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.471},"diagnostics":{"published_claims":25,"factual_claims":25,"claims_with_linked_evidence":25,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-11-16T04:46:35.507901+00:00","observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":"2026-11-16T04:46:35.507901+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":25,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/tg-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/tg-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}